ArticleIndian journal of gastroenterology : official journal of the Indian Society of Gastroenterology2014
Olmesartan-related sprue-like enteropathy.
Article in Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 23 citations in OpenAlex.
- Olmesartan induced gastritis and enteropathy.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2024Article
- Angiotensin Receptor Blockers Associated Enteropathy-Brief Report.Journal of community hospital internal medicine perspectives · 2022Article
- Olmesartan is not associated with the risk of enteropathy: a Korean nationwide observational cohort study.The Korean journal of internal medicine · 2019Observational
- The first cases of collagenous sprue successfully treated with thioguanine.BMJ open gastroenterology · 2016Article
- Mechanisms and management of refractory coeliac disease.Nature reviews. Gastroenterology & hepatology · 2015Review
- Blockers of Angiotensin Other Than Olmesartan in Patients With Villous Atrophy: A Nationwide Case-Control Study.Mayo Clinic proceedings · 2015Article
- Olmesartan-Induced Enteropathy: An Unusual Cause of Villous Atrophy.GE Portuguese journal of gastroenterologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic diarrhea is a common clinical problem in gastroenterology practice and often difficult to diagnose the cause. Presence of villous atrophy in these subjects is not specific as differential diagnosis can be broad. Drug-induced diarrhea is often overlooked during the evaluation. We report a short series of such challenging small bowel diarrhea secondary to olmesartan-related sprue-like enteropathy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.